Total Clarity Wealth Management’s Edwards Lifesciences EW Stock Holding History

Total Clarity Wealth Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,343	Closed	-$128K	–	444
2022 Q2	$128K	Buy	+1,343	New	+$139K	0.07%	283
2022 Q1	–	Sell	-512	Closed	-$66K	–	412
2021 Q4	$66K	Sell	512 -94	-16%	-$11K	0.03%	360
2021 Q3	$69K	Buy	+606	New	+$69.2K	0.03%	358
2021 Q2	–	Sell	-256	Closed	-$21K	–	349
2021 Q1	$21K	Buy	+256	New	+$21.6K	0.01%	453
2020 Q1	–	Sell	-171	Closed	-$13K	–	239
2019 Q4	$13K	Buy	+171	New	+$13.4K	0.01%	461

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Total Clarity Wealth Management's EW Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Edwards Lifesciences (EW) in Q3 2022, closing a stake of 1,343 shares — an estimated $128K sold.

Total Clarity Wealth Management first reported a position in EW in Q4 2019 and held it in 5 quarters. The position peaked at $128K in Q2 2022. 1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.

Total Clarity Wealth Management reported no remaining Edwards Lifesciences position as of Q3 2022 after selling out during the quarter.
Total Clarity Wealth Management sold 1,343 Edwards Lifesciences shares in Q3 2022, an estimated $128K.
Total Clarity Wealth Management first reported a position in Edwards Lifesciences in Q4 2019 and held it in 5 quarters.
Total Clarity Wealth Management's Edwards Lifesciences position peaked at $128K in Q2 2022.
1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.